Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 26–50 of 7,816 matching trials · page 2 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Development and Empirical Evaluation of a Brief Lifestyle Intervention for Older Adults at Risk of Dementia Within an Integrated Medical-Preventive Grid-Based Service Model NCT07831616 Brief lifestyle intervention |
NA other |
NOT_YET_RECRUITING | 300 | Fujian Medical University OTHER |
2026-09-21 |
|
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease NCT04396873 11C-MC1; 11C-PS13; 18f-florbetaben Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 184 | National Institute of Mental Health (NIMH) NIH |
2026-09-18 |
|
Falls: A Marker of Preclinical AD NCT04949529 Runs in: United States · 1 site |
NA other |
COMPLETED | 355 | Washington University School of Medicine OTHER |
2026-09-18 |
|
DECIDE: Dyads and Families NCT05139290 Prototype Intervention Runs in: United States · 4 sites |
NA other |
WITHDRAWN | 0 | Emory University OTHER |
2026-09-18 |
|
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants NCT05469360 NIO752; NIO752; Matching placebo; NIO752; NIO752; NIO752; Matching placebo Runs in: Finland; France; Spain; Sweden · 10 sites |
PHASE1 other |
ACTIVE_NOT_RECRUITING | 38 | Novartis Pharmaceuticals INDUSTRY |
2026-09-18 |
|
Identifying Biomarkers in Alzheimer's Disease NCT05655650 Runs in: Hong Kong · 1 site |
NA other |
RECRUITING | 300 | Chinese University of Hong Kong OTHER |
2026-09-18 |
|
MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01) NCT06534437 MEN1703; Glofitamab Runs in: France; Poland; Spain; United Kingdom · 35 sites |
PHASE2 other |
RECRUITING | 178 | Ryvu Therapeutics SA INDUSTRY |
2026-09-18 |
|
Pilot Study of Cognitive Behavior Therapy With Role-plays in Virtual Reality for Children With Behavior Problems NCT06559800 YourSkills: Cognitive behavioral therapy for children/youth with ro... Runs in: Sweden · 1 site |
NA other |
COMPLETED | 10 | Karolinska Institutet OTHER |
2026-09-18 |
|
Pilot Study of Parent Training With Role-plays in Virtual Reality for Parents of Children With Behavior Problems NCT06559813 Step-by-step: A cognitive behavioral parent program with role-plays... Runs in: Sweden · 1 site |
NA other |
COMPLETED | 8 | Karolinska Institutet OTHER |
2026-09-18 |
|
Pilot Study of Hospital GamePlan4Care NCT06634368 Hospital GamePlan4Care; Health Education Runs in: United States · 1 site |
NA other |
COMPLETED | 47 | VA Office of Research and Development OTHER_GOV |
2026-09-18 |
|
A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia. NCT06823752 Lemborexant 10 MG; Placebo Runs in: Australia · 1 site |
PHASE2 other |
RECRUITING | 20 | Woolcock Institute of Medical Research OTHER |
2026-09-18 |
|
Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment NCT07149038 Cerogrin; Sham Device Runs in: South Korea · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 24 | Neurogrin Inc. INDUSTRY |
2026-09-18 |
|
Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease NCT07221344 ARO-MAPT-SC; Placebo Runs in: Canada; New Zealand · 4 sites |
PHASE1|PHASE2 other |
RECRUITING | 112 | Arrowhead Pharmaceuticals INDUSTRY |
2026-09-18 |
|
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease NCT07599670 ABBV-1758; Placebo for ABBV-1758; ABBV-1758; Placebo for ABBV-1758 Runs in: China; United States · 13 sites |
PHASE1|PHASE2 other |
RECRUITING | 210 | AbbVie INDUSTRY |
2026-09-18 |
|
The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment NCT07650318 VR-Based Cognitive Training Plus Standard Diabetes Care; Traditiona... Runs in: China · 1 site |
NA other |
RECRUITING | 40 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School OTHER |
2026-09-18 |
|
Assessment of Changes in Autonomy Through Analysis of Smartphone Usage Data in Patients With Alzheimer's Disease NCT07826975 Data collection; Neuropsychological assesment; Autonomy questionnaire |
NA other |
NOT_YET_RECRUITING | 100 | Poitiers University Hospital OTHER |
2026-09-18 |
|
Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial NCT07827196 High frequency transcranial random noise; Sham high frequency trans... Runs in: China · 1 site |
NA other |
RECRUITING | 40 | Anhui Medical University OTHER |
2026-09-18 |
|
Phase 2 Study of AV-1959R in Individuals With Preclinical Alzheimer's Disease NCT07827768 AV-1959R; Placebo |
PHASE2 other |
NOT_YET_RECRUITING | 160 | Institute for Molecular Medicine OTHER |
2026-09-18 |
|
VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and Parkinsonism NCT07827963 Multimodal visuospatial and topographical memory assessment Runs in: Italy · 3 sites |
NA other |
NOT_YET_RECRUITING | 80 | IRCCS San Raffaele Roma OTHER |
2026-09-18 |
|
Effects of Application of Oral Moisturizers on Microbiota Homeostasis in Long-Term Care Patients NCT07828600 oral moisturizer Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 17 | Meiho University OTHER |
2026-09-18 |
|
Memory Improvement Through Nicotine Dosing (MIND) Study NCT02720445 Nicotine Transdermal Patch; Placebo Patch Runs in: United States · 36 sites |
PHASE2 other |
COMPLETED | 348 | University of Southern California OTHER |
2026-09-17 |
|
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia NCT03225144 Runs in: United States · 1 site |
NA other |
RECRUITING | 360 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2026-09-17 |
|
ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions NCT04865172 Remote collection of passive and active data for 28 consecutive days Runs in: France · 1 site |
NA other |
COMPLETED | 44 | Institut National de la Santé Et de la Recherche Médicale, France OTHER_GOV |
2026-09-17 |
|
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease NCT05295615 ECHS AD Device Runs in: United States · 1 site |
NA other |
RECRUITING | 40 | Herrick Medical LLC INDUSTRY |
2026-09-17 |
|
rTMS in Older Adults With MCI and AUD NCT05896332 Active, Open Label iTBS-rTMS Runs in: United States · 2 sites |
PHASE1 other |
ACTIVE_NOT_RECRUITING | 35 | Medical University of South Carolina OTHER |
2026-09-17 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial